Company Comparison
DNA Script vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | DNA Script | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Paris, France | South San Francisco, California |
| Founded | 2014 | 2006 |
| Status | Active | Active |
| Last Funding Stage | Series B | — |
| Total Funding | $134M | — |
| Valuation | — | — |
What They Build
DNA Script
Biotechnology company developing enzymatic DNA synthesis technology to enable on-demand, decentralized production of synthetic DNA for research and therapeutics.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
DNA Script
Sector Overlap
Both DNA Script and 23andMe operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.